Let's talk medical research

Clinical trial patient recruitment is an important aspect of medical research, but unfortunately, it is also one of the challenges. There are many regulations surrounding how information about trials can be shared with patients, and because outreach materials must be approved by the Institutional Review Board (IRB) before a campaign launches, planning a recruitment campaign requires a good deal ...

At Antidote, we believe that getting to know patients is about more than making an initial connection. As a digital patient engagement company with a database of 400,000 users, we know a lot about finding patients — but we also know how to keep them engaged.

Sickle cell disease (SCD) refers to a genetically inherited set of red blood cell disorders that are present from birth. Millions of people are impacted by SCD each year, but it disproportionately impacts Black and African American populations, occurring in about 1 out of every 365 Black or African-American births.

Successful clinical trial patient recruitment is a multi-step process that is worth taking the time to thoroughly understand. Clinical trial recruitment companies often make mention of thorough research, rigorous testing, and continuous optimization — but what does that mean in practical terms?

Strong clinical trial recruitment strategies start from a place of patient centricity, incorporating a variety of outreach methods designed to educate and engage potential participants. Creating a structured clinical trial patient recruitment plan before outreach begins is a smart way to ensure that the process is organized, efficient, and keeps the patient experience as the top priority.

When creating a clinical trial protocol, it’s important for sponsors to consider how each requirement impacts the patients who are taking part. While participating in a clinical trial can be beneficial for many reasons, it can also place a burden on patients who choose to participate. Complications with scheduling, transportation, and instructions can all create friction for patients — and can ...

There are many things that may influence how an individual reacts to a certain drug, medical device, or treatment plan. This can include age, biological sex, disabilities, chronic comorbidities, geographical location, gender identity, race, and ethnic background, and more — all of which should be considered in the medical decision-making process.

Gaining insight into medical conditions is what clinical trials are all about, but the data acquired is inevitably specific to the study participants — and in many cases, this means that racial and ethnic minorities are underrepresented in the results. Conducting medical studies is vital to discovering new therapies for conditions, but to do this effectively, researchers must ensure that their ...

Recruiting an adequate number of qualified participants is one of the most important aspects of a successful clinical trial — but it is also considered one of the most difficult. Clinical trial recruitment costs make up a major portion of the expenses that study sponsors incur, and when trials have to be delayed due to a lack of participants, each day of the setback can cost sponsors between ...

Across all genders and ethnic groups, cardiovascular disease is the leading cause of death in the United States. It is estimated that 8.8 million adults above age 20 have had a heart attack, and 7.6 million have had a stroke. These events can occur for many reasons, but a lesser-known risk factor is elevated lipoprotein(a) (Lp(a)).